Extremity Reconstruction Surgeries to Gain from 3D Implants

San Francisco, California, May 26, 2017:  The report titled, “Extremity Reconstruction Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025” by TMR Research discusses the major growth drivers, restraints, and trends in the market. An analysis of the value chain, market overview, market figures, market attractiveness, and an evaluation of the key segments has been included in the report.

The growing prevalence of abnormalities, injuries, and congenital deformities in the lower or upper extremity of the body has been encouraging the growth of the market over the past few years. The increasing need for reconstructive surgical procedures and the rising demand for implant devices for elbow, wrist, shoulder, foot, ankle joints, and digits have been some of the primary growth drivers of the market for extremity reconstruction.

Another prominent catalyst of the global market for extremity reconstruction is the growing pool of geriatric population. The Centers of Disease Control and Prevention estimates that as the geriatric population in the U.S. rises, the number of arthritis patients will reach 78 million by the end of 2040. Moreover, as joint disorders including osteoarthritis and rheumatoid arthritis are becoming more frequent by the day, the demand for extremity reconstruction is likely to shoot up. Diabetes and obesity are some other health conditions that have been contributing for the escalating demand for extremity reconstruction.

On the downside, the global market for extremity reconstruction can face restrictions owing to the lack of favorable reimbursements. However, the emergence of novel technologies such as 3D implants can further the growth of the market for extremity reconstruction. Arthritis patients are increasingly preferring 3D implants that offer quicker recovery, lesser pain, and better motion. For instance, Zimmer Biomet’s new 3D printed ankle fusion system gained approval of the U.S. Food and Drug Administration (FDA) in February 2016.

By geography, the global market for extremity reconstruction can be segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America is likely to hold the leading position in the global market for extremity reconstruction, due to the growing awareness about the advantages of extremity reconstruction, apart from favorable reimbursements, expanding geriatric population and development of new technologies.

The extremity reconstruction market in Asia Pacific is expected to flourish at a cracking pace, driven by the increased adoption of advanced and innovative technologies, presence of a vast patient pool, and improved standard of living of people.

Integra Lifesciences Holdings Corporation, Smith & Nephew plc, Arthrex, Inc., Wright Medical Group N.V., DePuy Synthes, Skeletal Dynamics LLC, Stryker Corporation, Acumed, Inc., Zimmer Biomet Holdings, Inc., and CONMED Corporation are some companies operating in the global market for extremity reconstruction.